Roche Joins in Spanish Research Cooperation for Personalized Treatment of Hepatitis B and C

Roche Diagnostics (

) is cooperating with the Spanish Vall d'Hebron Institute of Research, the Networking Biomedical Research Centre in Liver and Digestive Diseases, and the software producer Advanced Biological Laboratories Therapy Edge Spain in a study designed to resolve the current limitations that prevent the individualization of anti-HBV and anti-HCV (hepatitis B and C) treatments. The project will utilize Roche's 454 Sequencing Systems and bioinformatics analysis, together with other genetic and molecular analytical techniques. Ultimately, the research project aims to identify personalized treatment for each individual while minimizing the healthcare costs and side effects experienced by subjects.